C. Eichman

Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells.

E. Ohlstein, A. Truneh, C. Sung, 1997, The Journal of pharmacology and experimental therapeutics.

Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.

P. Young, T. Porter, C. Silverman, 1998, Journal of immunology.

Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhi CD4+ T cells correlates with suppression of psoriasis and colitis.

D. Coppola, Laura Healy, A. Truneh, 2002, International Immunopharmacology.

CD4 mAb induced apoptosis of peripheral T cells: multiparameter subpopulation analysis by flow cytometry using Attractors.

R. Sweet, J. Fishman-Lobell, A. Truneh, 2001, Journal of immunological methods.

The Identification and Characterization of the Marine Natural Product Scytonemin as a Novel Antiproliferative Pharmacophore

William H Gerwick, Christopher S. Stevenson, Robert S Jacobs, 2002, Journal of Pharmacology and Experimental Therapeutics.

Effects of rrSCF on multiple cytokine responsive HPP-CFC generated from SCA+Lin- murine hematopoietic progenitors.

P. Quesenberry, D. Deacon, P. Lowry, 1991, Experimental hematology.

Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.

D. Olive, M. Hurle, R. Sweet, 1996, Molecular immunology.

Analysis of CD28 Interactions with Its Cognate Counter-Receptors CD80 and CD86

D. Olive, I. Kariv, M. Hurle, 1996 .